RHeference
  • Allele
    • List
    • Search
  • References
    • All
    • By Author
    • By Journal
  • Documentation
  • Statistics
  • Search
    • By name
    • By mutation
    • In exons
    • Complex
  • Contact

Article

Evaluation of the applicability and effectiveness of a molecular strategy for identifying weak D and DEL phenotype among D- blood donors of mixed origin exhibiting high frequency of RHD*Ψ. Dezan MR, Guardalini LGO, Pessoa E, Ribeiro IH, Oliveira VB, Luz F, Novac DR, Gallucci A, Bonifácio S, Gomes F, Levi JE, Pereira AC, Krieger JE, Mendrone-Junior A, Rocha V, Dinardo CL. Transfusion, 2018. [Citation]

Annotations by Allele

  • RHD or DIIIa-CEVS(4-7)-D - partly characterized or subtypes not separated: RH1 (adsorption-elution was not performed)
  • RHD or DIIIa-CEVS(4-7)-D - partly characterized or subtypes not separated: Prevalence
  • RHD*1153+1A (IVS8+1A, RHD*01N.26): RH1 (adsorption-elution was not performed)
  • RHD*1153+1A (IVS8+1A, RHD*01N.26): otherHaplotype
  • RHD*1153+1A (IVS8+1A, RHD*01N.26): Prevalence
  • RHD*1154-31T (IVS8-31T, DEL37): Prevalence
  • RHD*1154-31T (IVS8-31T, DEL37): RH1 (adsorption-elution was not performed)
  • RHD*1154-31T (IVS8-31T, DEL37): otherHaplotype
  • RHD*1195A (weak D type 45): RH1 (negative at indirect antiglobulin phase by solid-phase method, suppressive effect of RhCe assumed; adsorption-elution was not performed)
  • RHD*1195A (weak D type 45): otherHaplotype
  • RHD*1195A (weak D type 45): Prevalence
  • RHD*1227A (DEL1): RH1 (adsorption-elution was not performed)
  • RHD*1227A (DEL1): otherHaplotype
  • RHD*1227A (DEL1): Prevalence
  • RHD*1227A,149-29C (IVS1-29C): Prevalence
  • RHD*1227A,149-29C (IVS1-29C): RH1 (adsorption-elution was not performed)
  • RHD*1227A,149-29C (IVS1-29C): otherHaplotype
  • RHD*149-29C (IVS1-29C, DEL32): RH1 (adsorption-elution was not performed)
  • RHD*149-29C (IVS1-29C, DEL32): otherHaplotype
  • RHD*149-29C (IVS1-29C, DEL32): Prevalence
  • RHD*330_331delGT (RHD*01N.35): RH1 (adsorption-elution was not performed)
  • RHD*330_331delGT (RHD*01N.35): otherHaplotype
  • RHD*330_331delGT (RHD*01N.35): Prevalence
  • RHD*833A (weak D type 38): Prevalence
  • RHD*833A (weak D type 38): RH1 (negative at indirect antiglobulin phase by solid-phase method, suppressive effect of RhCe assumed; adsorption-elution was not performed)
  • RHD*833A (weak D type 38): otherHaplotype ("The final genotype was RHef00311/RHD-CE(4-7)-D with RHCE*Ce and RHCE*ceS")
  • RHD*D-CE(3)-weak D type 4.0 (RHD*01N.72): RH1 (adsorption-elution was not performed)
  • RHD*D-CE(3)-weak D type 4.0 (RHD*01N.72): otherHaplotype
  • RHD*D-CE(3)-weak D type 4.0 (RHD*01N.72): Prevalence
  • RHD*Dpsi (RHD*08N.01): otherHaplotype
  • RHD*Dpsi (RHD*08N.01): otherHaplotype
  • RHD*Dpsi (RHD*08N.01): Prevalence
  • RHD*Dpsi (RHD*08N.01): RH1 (adsorption-elution was not performed)